#D10TS_Picks 👉 #RBRK : $113.19 Rubrik reported Q2 FY2027 revenue of $427.3M, up 38% YoY, driven by strong demand for cloud data security, cyber resilience and AI-related security solutions. Subscription annual recurring revenue (ARR) grew 33% YoY to $1.66B, and the company raised its FY2027 outlook. Continued subscription growth and improving cash-flow margins are key catalysts to watch. Resistance: $115.40, $117.40 Support: $111.50, $109.50 For Detailed Analysis: https://t.me/c/2454754655/8421 👉 #DXC : $14.26 DXC Technology is focusing on business transformation, AI-enabled IT services and operational efficiency. The company reported Q1 FY2027 revenue of approximately $3.0B, down 5% YoY. A potential $2.4B sale of its insurance software and services division could support its portfolio simplification strategy, although the deal remains subject to finalization. Strong recent trading volume and progress on asset sales are catalysts to watch. Resistance: $14.50, $15.00 Support: $13.50, $12.30 For Detailed Analysis: https://t.me/c/2454754655/10461 👉 #VSTM : $8.62 Verastem Oncology combines an FDA-approved ovarian cancer treatment with a promising pipeline targeting KRAS-driven cancers. VS-7375 has shown encouraging early clinical activity, with Phase 3 preparations and TARGET-D enrollment completion targeted by year-end 2026. RAMP 301 results are expected in mid-2027. Potential dilution and clinical trial risks remain key concerns. For Detailed Analysis: https://t.me/c/2454754655/10392 👉 Join our ThinkSabio Stocks WL999 Group To join, simply visit our ThinkSabio Community Page or access the ThinkSabio Bot. 🌐 https://www.thinksabio.com/community D9.jpg